Armin J Grau Selected Research

Armin J Grau Research Topics

Disease

19	Stroke (Strokes) 11/2021 - 04/2003
15	Ischemic Stroke 01/2020 - 11/2002
4	Periodontitis 01/2020 - 02/2004
3	Thrombosis (Thrombus) 06/2017 - 04/2003
3	Infections 03/2011 - 02/2006
2	Atrial Fibrillation 01/2017 - 07/2010
2	Inflammation (Inflammations) 07/2014 - 06/2003
2	Human Influenza (Influenza) 03/2011 - 04/2010
2	Brain Ischemia (Cerebral Ischemia) 08/2004 - 07/2004
1	COVID-19 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Necrosis 01/2020
1	Septic Shock (Toxic Shock Syndrome) 01/2020
1	Embolism (Embolus) 06/2017
1	Embolic Stroke 01/2017
1	Mycoplasma Pneumonia 11/2016
1	Chronic Progressive External Ophthalmoplegia (Progressive External Ophthalmoplegia) 05/2012
1	Respiratory Insufficiency (Respiratory Failure) 05/2012
1	Hypertension (High Blood Pressure) 07/2010
1	Hyperlipidemias (Hyperlipidemia) 07/2010
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2008
1	Transient Ischemic Attack 01/2008
1	Blood Vessel Dissection 09/2007
1	Communicable Diseases (Infectious Diseases) 02/2006
1	Bronchitis 02/2006
1	Chronic Periodontitis 02/2006
1	Ischemia 09/2005
1	Carotid Artery Diseases 07/2004
1	Myocardial Infarction 05/2004
1	Peripheral Arterial Disease 05/2004
1	Infarction (Infarctions) 08/2003
1	Lacunar Stroke 04/2003
1	Hemorrhage 04/2003

Drug/Important Bio-Agent (IBA)

4	C-Reactive ProteinIBA 01/2020 - 10/2003
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2010 - 04/2003
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 07/2014
3	Indicators and Reagents (Reagents)IBA 11/2018 - 02/2004
3	Fibrinogen (Factor I)FDA Link 09/2005 - 10/2003
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2021 - 07/2010
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 11/2021 - 04/2003
2	AntibodiesIBA 01/2020 - 11/2016
2	LigandsIBA 01/2020 - 06/2003
2	AntigensIBA 01/2020 - 02/2006
2	Immunoglobulin A (IgA)IBA 01/2020 - 11/2016
2	Immunoglobulin G (IgG)IBA 01/2020 - 11/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 08/2003
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 08/2004
2	Matrix Metalloproteinase 8 (Neutrophil Collagenase)IBA 01/2018 - 07/2014
2	Peroxidase (Myeloperoxidase)IBA 01/2018 - 07/2014
2	Dihydrotachysterol (AT 10)IBA 09/2005 - 11/2002
2	EnzymesIBA 08/2004 - 08/2003
2	Clopidogrel (Plavix)FDA Link 05/2004 - 04/2003
1	InterleukinsIBA 01/2020
1	Selenoproteins (Selenoprotein)IBA 01/2020
1	lipopolysaccharide-binding proteinIBA 01/2020
1	lipoprotein A-IIBA 01/2020
1	Phospholipid Transfer ProteinsIBA 01/2020
1	factor AIBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Apolipoproteins B (ApoB)IBA 01/2020
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2020
1	Chemokine ReceptorsIBA 01/2020
1	E-SelectinIBA 01/2020
1	Lipopolysaccharide ReceptorsIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	ChemokinesIBA 01/2020
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2020
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2020
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020
1	LipopolysaccharidesIBA 01/2020
1	Lipoproteins (Lipoprotein)IBA 01/2020
1	Tissue Inhibitor of MetalloproteinasesIBA 01/2018
1	Matrix Metalloproteinases (MMPs)IBA 01/2018
1	Tissue Inhibitor of Metalloproteinase-1IBA 01/2018
1	RNA (Ribonucleic Acid)IBA 06/2017
1	Lys Transfer RNAIBA 05/2012
1	Tissue Plasminogen Activator (Alteplase)FDA Link 03/2011
1	rheinIBA 09/2010
1	Dipyridamole (Persantine)FDA LinkGeneric 07/2010
1	Heparin (Liquaemin)FDA LinkGeneric 07/2010
1	Oseltamivir (Tamiflu)FDA Link 04/2010
1	Neuraminidase (Sialidase)IBA 04/2010
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2008
1	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 01/2008
1	AnticoagulantsIBA 09/2007
1	Cytotoxins (Cytolysins)IBA 08/2004
1	NucleotidesIBA 07/2004
1	Toll-Like Receptor 4IBA 07/2004
1	ImmunosorbentsIBA 08/2003
1	Cytokine Receptor gp130IBA 08/2003
1	CytokinesIBA 08/2003
1	Adenosine (Adenocard)FDA LinkGeneric 08/2003
1	Lysosomal Membrane ProteinsIBA 11/2002
1	N 30IBA 11/2002

Therapy/Procedure

3	Therapeutics 01/2020 - 07/2010
2	Length of Stay 01/2017 - 10/2014
1	Dental Care 11/2016
1	Thrombolytic Therapy 07/2010